Emerging studies suggest this peptide, a dual stimulator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , could provide a significant advancement for weight loss . Initial human investigations have indicated considerable decreases in visceral fat , potentially exceeding other weight-loss treatments. Nevertheless , further stu